The endothelium plays a critical role in the control of vasomotor tone by the 
Thus, the purpose of the present study was to assess the coronary vasomotor response to different stimuli of endothelium-dependent relaxation very early in the development of atherosclerosis in humans. Based on the results of experimental studies and preliminary data in patients from our laboratory,23 we hypothesized that there is a hierarchical structure in the impairment of endothelium-dependent responses with progressive disease.
Methods

Patient Population
Thirty-eight patients undergoing routine diagnostic cardiac catheterization were studied. These patients were classified into four groups based on their history and the presence or absence of atherosclerosis on the diagnostic coronary angiogram. Patients with unstable angina, recent myocardial infarction, valvular heart disease, or clinical evidence of heart failure were excluded. Written, informed consent was obtained from all patients before the study. The study protocol had been approved by the ethical committee of the University of Freiburg. Group 1. Nornal control patients. Eleven patients with angiographically normal coronary arteries served as control subjects. Patients with a history of arterial hypertension (systolic blood pressure >150 mm Hg and diastolic blood pressure >90 mm Hg), the presence of left ventricular hypertrophy, diabetes mellitus, and hypercholesterolemia (total cholesterol serum level >210 mg%) were excluded from the normal control group. The mean cholesterol serum level was 186 mg%, ranging from 143 to 208 mg%. The mean age of these patients was 49.2 years, three were women, and eight were men. All subjects had angiographically normal, smooth coronary arteries without luminal irregularities and without evidence of segmental wall motion abnormalities on left ventricular cineangiograms. The cause for referral for diagnostic coronary angiography was atypical chest pain in nine patients and intermittent left bundle branch block in two patients.
Group 2. Patients with hypercholesterolemia but with angiographically normal coronary arteries. Nine patients were studied who had angiographically normal, smooth coronary arteries without any luminal irregularities but with hypercholesterolemia (LDL serum levels >180 mg% Wilson and White,24 who demonstrated that the administration of 12 mg papaverin, injected into the left main artery, produced maximal coronary hyperemia. Eighty seconds after papaverin-induced increase in blood flow in the left anterior descending coronary artery, a coronary angiogram was obtained for measuring the diameter of the proximal segment of the artery exposed to increased blood flow but not directly to papaverin itself. Reflux of papaverin into the proximal artery segment was excluded by power injection of contrast material through the Doppler catheter, and potential effects of recirculating papaverin were assessed by measuring the diameter of the proximal circumflex coronary artery as the reference vessel not exposed to increased blood flow.
Ten minutes after papaverin infusion, acetylcholine was selectively infused into the left anterior descending coronary artery by the Doppler catheter. Increasing dosages were used to achieve the estimated final blood concentrations in the coronary bed of 10`8 10-7, and 1o6 M (assuming a blood flow of 80 ml/min) at an infusion rate of 2 ml/min, lasting 3 minutes for each concentration. Stepwise acetylcholine infusions were terminated when either vessel occlusion occurred or the largest dose (10-6 M) was reached. To compare the vasomotor response of identical coronary segments to acetylcholine and increased blood flow, the Doppler catheter was withdrawn into the proximal artery segment during the acetylcholine studies, where the response to increased blood flow was measured. The sequence of interventions with either papaverin or acetylcholine was randomly varied so that 21 patients received the papaverin infusion before the acetylcholine infusion and 17 patients received intracoronary infusion of increasing doses of acetylcholine before the assessment of flow-dependent dilation by infusion of papaverin. In any case, at least a 10-minute recovery period was allowed between all interventions.
Throughout the study, phasic and mean intracoronary blood flow velocities, heart rate, and aortic pressure (by the guiding catheter) were continuously measured. Serial hand injections of nonionic contrast material (Ultravist, Schering AG, Berlin), were administered during the control phase, at the end of cold pressor testing, at the recontrol phase after cold pressor testing, at the end of each acetylcholine infusion, at the recontrol phase after acetylcholine infusion, and 80 seconds after subselective infusion of papaverin. Before completion of the study, 0.25 mg nitroglycerin was injected into the left main stem by the guiding catheter, and a final angiogram was then obtained to assess the vasodilatory capability of the coronary arteries. Quantitative Coronary Angiography
Coronary angiography was performed with a simultaneous biplane multidirectional isocentric radiological system (Siemens Bicor, Erlangen, FRG). The coronary arteries under study were positioned near the isocenter, and special care was taken to avoid overlapping of coronary segments. Biplane cineangiograms were recorded at a frame rate of 25 frames/ sec. In the patients with angiographic evidence of atherosclerosis, the angiograms were examined by two investigators, and the proximal segment of the left anterior descending coronary artery was classified as smooth or irregular by a consensus decision before analysis. For quantitative analysis, end-diastolic cineframes were videodigitized and stored in the image analysis system (Mipron I, Kontron electronics, Eching, FRG) in a 512x512 matrix with an eight-bit gray scale. With the 12-cm field of view, the resulting pixel density was 7.3 pixels/mm. The geometrical resolution of the radiological imaging chain is greater than 4 line pairs/mm. Quantitative coronary angiography by automatic contour detection was performed by a previously described and validated method that incorporates a geometric edge differentiation technique.1921 Calculation of the exact radiological magnification factor of the measured segment was used to scale the data from pixels to millimeters as previously described. 25 The accuracy and precision of this technique, as well as the reproducibility of serial measurements under routine clinical conditions, have been established in previous studies.19 '21 Six-to 8-mm segments of the proximal left anterior descending coronary artery (the vessel under study) and of the circumflex coronary artery (the reference vessel during the selective infusion of papaverin and acetylcholine into the left anterior descending coronary artery) were measured. A series of diameter measurements were obtained for each scanline for the length of the arterial segment in which diameter versus segment length was plotted in graph form, and the mean diameter was calculated. Whenever possible, measurements were obtained for both views of the biplane images with the radiopaque tip of the Doppler catheter for identification of corresponding vessel segments, and the vessel's cross-sectional area was calculated from both views assuming an elliptical shape. Only single-plane analysis was performed for those coronary segments demonstrating overlapping with other parts of the coronary tree in one view; in those cases (eight of 38 patients or 21%), vessel cross-sectional area was calculated assuming a circular shape.
Derived Parameters
For estimating directional changes in coronary blood flow, a coronary flow index was calculated by multiplying the mean Doppler-derived blood flow velocity with the computed cross-sectional area of the vessel segment. Because the injection of contrast material into the coronary circulation resulted in the typical biphasic response due to hyperemic effects, that is, an initial decrease followed by an increase in coronary blood flow velocity, the mean blood flow velocity immediately before the contrast injection was used for estimating coronary blood flow. To exclude limitations of coronary artery flow due to epicardial coronary artery constriction in response to acetylcholine, we calculated the coronary flow index only when the vessel's cross-sectional area reduction did not exceed 50% in the most constricting epicardial artery segment, as previously suggested by Treasure et al. 26 An index of coronary vascular resistance was calculated by the ratio of the mean aortic pressure divided by the coronary flow index.
Statistical Analysis
All data are expressed as mean±SD. Statistical comparisons were made by analysis of variance for repeated measures followed by the Student-Newman-Keuls test. Differences between groups were evaluated by analysis of variance followed by Bonferroni's t test. Statistical significance was assumed if the null hypothesis could be rejected at the 0.05 probability level.
Results
Systemic Hemodynamics
The systemic hemodynamic responses to sympathetic stimulation are summarized in Table 1 . Cold pressor testing led to similar increases in heart rate and blood pressure in all four groups of patients. Subselective intracoronary infusion of 7 mg papaverin and infusion of acetylcholine to the final estimated blood concentration of 10-6 M had no effect on heart rate or aortic pressure in any of the four groups ( Table 2) . Injection of 0.25 mg nitroglycerin into the left main coronary artery slightly, but significantly (p<0.01), increased mean±SD. Group 1, normal control patients; group 2, patients with hypercholesterolemia but with angiographically normal coronary arteries; group 3, patients with coronary artery disease but with an angiographically normal proximal segment of the left anterior descending coronary artery; group 4, patients with minimal disease of the left anterior descending coronary artery; before papaverine, before selective infusion of 7 mg papaverin; after papaverin, 80 seconds after selective infusion of 7 mg papaverin; before max acetylcholine, before selective infusion of acetylcholine; after max acetycholine, at the end of selective infusion of the maximally attained acetycholine concentration.
heart rate by 5.1±1.9% and decreased mean aortic pressure by 3.9±1.8% in all four groups.
Responses of Epicardial Coronary Arteries
There were no significant changes in the luminal area of the circumflex coronary artery of patients in any of the four groups during subselective infusion of acetylcholine or papaverin into the left anterior descending coronary artery. Thus, potential effects of the injected contrast material itself or those of recirculating papaverin were excluded.
Normal control arteries (group 1). In the normal control group, the proximal left anterior descending coronary artery segments of all patients dilated in response to all three stimuli (Figure 1 ). Cold pressor testing dilated the arteries by 18.5+7.6% from a mean control luminal area of 9.4+2.2 to 11.3±2.5 mm2 (p<O.OOl); the maximal dose of acetylcholine dilated the arteries by 24.7±15.9% from a mean control luminal area of 9.2±2.1 to 11.2±3.1 mm2 (p<0.001); and flow-dependent dilation increased the mean control luminal area by 22.2±7.9% from 9.7±1.9 to 11.6±2.4 mm2 (p<0.001). Intracoronary administration of nitroglycerin increased mean luminal area by 41.3±14.0% (Figure 1 ).
Angiographically normal arteries in patients with hypercholesterolemia (group 2). In all nine patients with hypercholesterolemia but with angiographically normal coronary arteries, the proximal left anterior descending coronary artery segments dilated in response to cold pressor testing by 14 .2±4.6% from a mean control luminal area of 9.9+2.1 to 11.5+2.4 mm2 (p<0.001) (Figure 1 ). However, all identical coronary artery segments demonstrated dose-dependent vasoconstriction to intracoronary infusion of acetylcholine; mean control luminal area was reduced by 35.9±12.7% from 9.6±2.3 to 6.4±3.4 mm2 (p<0.001) after the maximal dose ( Figure 1 ). In one patient, 10`M acetylcholine produced profound vasoconstriction so that no further increase in dosage was attempted. In contrast, papaverin-induced increases in blood flow resulted in a 15.4±4.9% increase ( Figure 1 ) in mean control luminal area from 10.2±2.6 to 11.8±3.1 mm2 (p<0.001). Intracoronary administration of nitroglycerin increased mean luminal area by 29.8±12.3% (Figure 1) .
Thus, the vasomotor response of angiographically normal coronary arteries in patients with hypercholesterolemia was characterized by a selective impairment of acetylcholine-induced vasodilation of the epicardial coronary arteries (Figure 2) .
Angiographically normal proximal left anterior descending coronary artery segments in patients with coronary artery disease (group 3). All angiographically normal left anterior descending coronary artery segments in the nine patients with evidence of coronary artery disease elsewhere in the coronary system vasoconstricted in response to cold pressor testing by 18.7±7.9% from a mean control luminal area of 8.9±2.2 to 7.3 ±2.5 mm2 (p<0.001) after cold pressor testing (Figure 1 ). The identical coronary artery segments also demonstrated dose-dependent vasoconstriction to intracoronary administration of acetylcholine by 26.2±8.7% from a mean control luminal area of 8.7±2.3 to 6.7±2.8 mm2 after the maximal dose, at which the vessel was still patent. The infusion of acetylcholine caused temporary vessel occlusion in three of these patients at the maximal dose of 10-6 M. In contrast, increases in blood flow still elicited vasodilation of the proximal left anterior descending coronary artery segments by 20.4±8.7% (Figure 1) (Figure 2 ).
Minimal disease of the left anterior descending coronary artery (group 4). All coronary artery segments with luminal irregularities vasoconstricted in response to cold pressor testing by 19 .9±6.3% ( Figure  1 ) from a mean control luminal area of 8.4±2.3 to 6.9±2.6 mm2 after testing (p<0.001), and they vasoconstricted dose dependently to acetylcholine by 34.5±10.7% (Figure 1 ) from a mean control luminal area of 8.2±2.5 to 5.6±3.1 mm2 after the maximal dose. The infusion of acetylcholine at an estimated concentration of 10-6 M resulted in temporary occlusion of the left anterior descending coronary artery in two of these patients. Increases in blood flow caused only a slight, but statistically nonsignificant, increase in the luminal area of proximal artery segments by 5.8±5.4% (Figure 1 ) from 8.2±3.0 at control to 8.6±3.1 mm2. Intracoronary administration of nitroglycerin increased luminal area by 20.6±9.9% (p<0.05 versus groups 1 and 3). Figure 2 illustrates the progressive impairment in endothelium-mediated vasoactive functions of epicardial coronary arteries with different early stages of atherosclerosis, beginning with a selective endothelial dysfunction in angiographically normal arteries of patients with hypercholesterolemia and progressively worsening to a complete loss of endothelium-mediated vasodilation in coronary arteries with angiographic evidence of atherosclerosis.
Responses of Coronary Resistance Vasculature
In the normal control group (group 1), coronary flow index increased by 442±123% (range, 286-699%) in " ' 1 .
, between increases in flow indexes and flow-mediated vasodilation of the proximal artery segment in the group 2 patients. However, no significant relation between flow-mediated vasodilation and increases in flow indexes was observed in patients with coronary artery disease (r=0.16 in group 3 and 3%t .
r=0.15 in group 4). N=11
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CPT hypercholesterolemia, those with elevated LDL serum levels (n=6) would have demonstrated a significantly (p<0.05) smaller reduction in coronary vascular resistance index in response to the maximal dose of acetylcholine (37.6±15.6% versus 57.8±10.7% decrease) despite a normal response to papaverin (397±144% increase in flow index).
Sympathetic stimulation by cold pressor testing decreased coronary vascular resistance similarly in the normal control group (group 1) and in patients with hypercholesterolemia (group 2), but it increased coronary vascular resistance in patients with coronary artery disease (groups 3 and 4, p<0.05 versus groups 1 and 2, respectively).
Thus, the coronary resistance vasculature demonstrated a selective impairment of vasodilation of the resistance vessels in response to the endotheliumdependent mediator acetylcholine in patients with hypercholesterolemia despite a normal response to the smooth muscle relaxant papaverin.
Discussion
The results of this study demonstrate that there is a progressive impairment in endothelium-mediated modulation of coronary vasomotor tone with different stages of early atherosclerosis in humans. In normal patients with angiographically normal coronary arteries and without risk factors for coronary artery disease, the vasomotor response to intracoronary administration of acetylcholine, increased blood flow, and sympathetic stimulation is characterized by an increase in epicardial artery luminal area. Patients with angiographically normal coronary arteries but with hypercholesterolemia and elevated plasma concentrations of LDL demonstrate a selective endothelial dysfunction with vasoconstriction in response to acetylcholine but preserved vasodilation in response to sympathetic stimulation and increased coronary blood flow. This selective endothelial dysfunction is not confined to the large epicardial conductance vessels but also includes the human coronary resistance vasculature. Angiographically normal coronary artery segments in patients with evidence of atherosclerosis elsewhere in the coronary system have lost their ability to dilate in response to acetylcholine and sympathetic stimulation, whereas their ability to dilate flow dependently is still intact. Atherosclerotic coronary arteries with angiographically visible luminal irregularities demonstrate a complete loss of endothelium-mediated vasoactive functions.
To interprete the progressive alterations in endothelium-dependent responses observed in the intact coronary circulation of patients with different early stages of atherosclerosis, the mechanisms of vasodilation induced by the different endothelium-dependent stimuli must be considered. Experimental studies strongly suggest that the vasodilation in response to increased flow is mediated by release of endothelium-derived relaxing factor (EDRF),26-28 possibly mediated by the signal of shear stress on the endothelium by stretch-activated ion channels.29-31 Our results demonstrated a strong linear correlation between relative increases in blood flow and luminal area changes of epicardial conductance vessels in the normal coronary vasculature, thereby indicating that changes in shear stress may at least, in part, contribute to the flow-mediated dilation in the intact human coronary circulation. Similar results were recently reported for the brachial artery in humans. 32 The mechanisms of vasodilation of normal epicardial coronary arteries in response to sympathetic stimulation is very likely to be mediated by endothelial cell a2-adrenergic receptors33 and increased shear stress due to augmentation of coronary blood flow and driving pressure,3435 thereby counteracting the direct a-adrenergic receptor-mediated vasoconstrictor effects.36 Acetylcholine causes endothelium-dependent dilation by acting on endothelial muscarinic receptors to initiate the release of EDRF.24 The EDRF-mediated vasorelaxation counteracts acetylcholine's direct vasoconstrictor effect on the muscarinic receptors of the vascular smooth muscle.
The most important finding of this study is the hierarchical structure in the impairment of endothelium-dependent responses to the three different stimuli in patients with progressive stages of atherosclerosis. Previous studies demonstrate that the normal vasodilator response of epicardial arteries to acetylcholine10,21,37 is reversed to a constrictor response in patients with risk factors for coronary artery disease despite angiographically smooth coronary arteries.38,39 These results suggest an abnormality of endothelial function, which either precedes atherosclerosis or represents an early marker of atherosclerosis not detectable by angiography.38 In the present investigation, the angiographically normal epicardial arteries of patients with hypercholesterolemia also exhibited a vasoconstrictor response to acetylcholine; however, the vasodilator response to increased coronary blood flow and to sympathetic stimulation was well preserved. Thus, our results demonstrate the loss of selective endothelium-mediated vasoactive functions very early in the development of atherosclerosis in patients with angiographically normal coronary arteries but with elevated plasma levels of LDL. These findings closely correspond to a number of experimental studies. Hypercholesterolemic animals without any evidence of structural alterations of the arterial wall demonstrate an impairment of receptor-mediated endothelium-dependent relaxations,7,40,4' but those mediated by norepinephrine or by the calcium ionophore A23 187 are still preserved.9"1''3 '15 By combining these previous experimental findings with our present findings in patients with intact coronary circulation, we can hypothesize that very early in the process of atherosclerosis during hypercholesterolemia in humans endothelium-dependent responses are impaired first by a depressed receptormediated initiation of the production or release of EDRF. This hypothesis is further substantiated by our finding that hypercholesterolemia selectively im-pairs endothelial function also in the coronary resistance vessels, even though small vessels do not develop atherosclerotic lesions with intimal or medial thickening. In patients with coronary artery disease, contrasting effects of acetylcholine with constriction of epicardial conductance arteries but with vasodilation of coronary resistance vessels have been reported42-44 and have been attributed to the lack of atherosclerotic lesions in the resistance vasculature, even when high-grade atherosclerotic lesions are present in the epicardial arteries. The present study is the first to demonstrate an impaired vasodilator response of coronary resistance vessels to acetylcholine in patients with hypercholesterolemia and a preserved vasodilator response of the resistance circulation to acetylcholine in patients with coronary artery disease but with normal LDL levels. Therefore, rather than reflecting atherosclerosis per se, the alterations in endothelial vasoactive function induced by hypercholesterolemia may implicate early changes in endothelial cell function important in the development of atherosclerosis in humans. However, although a number of experimental studies suggest that impairment of endothelium-dependent relaxation in diet-induced hypercholesterolemia may be specific for relaxations mediated by receptors, we cannot exclude that atherosclerosis not detectable by coronary angiography was already present in the patients with hypercholesterolemia and angiographically smooth coronary arteries. To ascertain that hypercholesterolemia itself induces alterations of muscarinic receptors with preservation of other features of endothelium-mediated relaxation would require histological data of the vessel wall, which obviously cannot be obtained from patients undergoing diagnostic coronary angiography.
The loss of a vasodilator response to sympathetic stimulation by cold pressor testing, in addition to the vasoconstrictor effects of acetylcholine, in angiographically normal epicardial coronary artery segments but with evidence of atherosclerosis elsewhere in the coronary system suggests a further impairment in endothelium-mediated vasoactive function in these patients. Intraoperative echocardiographic studies have demonstrated that in vivo coronary arterial atherosclerosis is far more extensive than that predicted by coronary angiography.45 Coronary artery segments without any angiographic narrowing in patients with angiographic evidence of coronary artery disease elsewhere in the coronary system demonstrated substantial intimal atherosclerosis by high-frequency echocardiography. Thus, the angiographically "normal" appearing coronary arteries demonstrating a vasoconstrictor response to sympathetic stimulation are probably in an early stage of atherosclerosis with mainly diffuse intimal thickening. Previous studies using intracoronary infusion of acetylcholine also demonstrated endothelial dysfunction in angiographically normal arteries of patients with coronary artery disease21,37 and of cardiac transplant patients, which is a population prone to accelerated graft atherosclerosis. 46 Whether the vasoconstrictor response of both epicardial and resistance vessels in patients with coronary artery disease represents an altered sensitivity of vascular adrenergic receptor stimulation or is mediated by vasoactive substances released from activated platelets during sympathetic stimulation47 remains to be determined. A number of experimental studies demonstrated the pivotal role of an intact endothelium for preventing intracoronary platelet aggregation with subsequent reductions in coronary blood flow during sympathetic stimulation. 48, 49 Despite impaired endothelial function in response to acetylcholine and sympathetic stimulation, flowmediated vasodilation was still preserved in angiographically normal arteries in patients with coronary artery disease. Thus, in the absence of a concomitant vasoconstrictor stimulus, increases in blood flow still elicited vasodilation, indicating preservation of the effects of EDRF released through the signal of shear stress in these vessel segments. However, when atherosclerosis was more advanced as evidenced by angiographically visible luminal irregularities of the analyzed vessel segments, then flow-mediated vasodilation was also abolished. In these atherosclerotic vessel segments, the vasodilator response to the smooth muscle relaxant, endothelium-independent, nitroglycerin was significantly reduced, too, indicating a general reduction in vasodilatory capability. Although the precise mechanisms of endotheliummediated vasodilation for the three different stimuli used in the present study cannot be directly assessed in the intact human coronary circulation, our results indicate that vasodilation in response to increased coronary blood flow is preserved until there is angiographic evidence of myointimal thickening of the arterial wall as indicated by luminal irregularities.
These observations in the intact human coronary circulation favorably correspond with recently published experimental results in pigs with different early stages of atherosclerosis.15 Endothelium-dependent responses progressively deteriorated during the process of atherosclerosis from an impairment of a variety of receptor-mediated endothelial functions during the early stages of atherosclerosis to a complete loss of endothelium-mediated relaxation when myointimal thickening with concomitant medial thickening of the arteries was present.15 However, we cannot exclude the possibility that, in coronary atherosclerosis, vasoconstrictor substances may be released with a smaller amount of EDRF. 50, 51 In summary, this study demonstrates a progressive impairment of endothelial vasoactive functions in coronary arteries with advancing early stages of atherosclerosis in the intact human coronary circulation, beginning with a selective endothelial dysfunction in angiographically normal arteries in patients with elevated serum LDL concentrations and progressively worsening to a complete loss of endothelium-mediated vasodilation in coronary arteries with angiographic ev-idence of atherosclerosis. 
